News
Teva Post Lupin Deal To Launch Austedo Generic Rival In 2033
Teva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as it focuses on the...
News
Fibrogen-Astellas Anaemia Drug Evrenzo Gets NICE Backing
Despite a high-profile FDA denial, FibroGen and its collaborators have been able to expand into new markets outside of the United States with Evrenzo,...
News
Drug Launch Prices Have Gone Up 20% Yearly For A Decade
As many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years: drug prices are significantly...
News
FDA Advisory Group Permits Bluebird Gene Therapy Amid Risks
Bluebird bio has persuaded an expert committee that the benefits of its gene therapy possibility, eli-cel, exceed the risks, at least in certain patients,...
News
Alnylam Shares Findings On Delivering siRNA Beyond The Liver
Alnylam has outlined their strategy for delivering siRNA to the central nervous system and other organs outside of the liver. The RNA specialist detailed...
News
With Keytruda, Merck Sees 80 Plus Eligible Oncology Wins
Merck & Co. was not at all a prominent oncology player before the advent of Keytruda. The New Jersey drugmaker wants to consolidate its supremacy...
News
Lunsumio, Blood Cancer Drug By Roche Gets Global Approval
Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a novel bispecific lymphoma medicine...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read